Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
Germany
/
Healthcare
/
Medios
ILM1
Medios
Aging European Populations And Advanced Therapies Will Energize Healthcare
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€32.00
52.9% undervalued
intrinsic discount
24 Aug
€15.06
1Y
-10.7%
7D
7.3%
Loading
1Y
-10.7%
7D
7.3%
Author's Valuation
€32.0
52.9% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€32.0
52.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-3m
2b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue €2.2b
Earnings €53.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.57%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.76%
Calculation
€53.21m
Earnings '28
x
18.67x
PE Ratio '28
=
€993.29m
Market Cap '28
€993.29m
Market Cap '28
/
27.89m
No. shares '28
=
€35.62
Share Price '28
€35.62
Share Price '28
Discounted to 2025 @ 4.76% p.a.
=
€30.98
Fair Value '25